I fail to understand how these three shares score relatively poorly to other stock. AZN in particular has moved from £70 to £88 in a month.  I accept it looks pretty overbought probably for defensive reasons, but they have had a couple of very successful drug launches this year. I was thinking it was a better place to put money than a bank account, but may have got passed that point now. OCDO looks like it really will make £42 within the next 2 years. All I hear is how expensive and overpriced it is. That was at£10! Anyone know how these scores are arrived at. Is it some clever computer software calculations or some other method?

Unlock the rest of this Article in 15 seconds

or Unlock with your email

Already have an account?
Login here